🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/10/1979 | 1,75 | 1,77 | 1,72 | 1,74 | -0,76% | 3,03% | 3.618.115 |
| 10/10/1979 | 1,78 | 1,78 | 1,71 | 1,75 | -2,58% | 3,73% | 8.439.754 |
| 09/10/1979 | 1,82 | 1,82 | 1,79 | 1,80 | -2,87% | 1,46% | 3.784.118 |
| 08/10/1979 | 1,87 | 1,89 | 1,85 | 1,85 | -1,06% | 2,30% | 2.735.280 |
| 05/10/1979 | 1,87 | 1,88 | 1,87 | 1,87 | +0,00% | 0,71% | 4.142.534 |
| 04/10/1979 | 1,86 | 1,88 | 1,86 | 1,87 | +0,35% | 1,25% | 2.640.960 |
| 03/10/1979 | 1,88 | 1,88 | 1,84 | 1,86 | -0,88% | 1,77% | 4.342.493 |
| 02/10/1979 | 1,81 | 1,89 | 1,79 | 1,88 | +4,04% | 5,50% | 7.157.002 |
| 01/10/1979 | 1,82 | 1,82 | 1,80 | 1,81 | -0,91% | 1,09% | 962.064 |
| 28/09/1979 | 1,83 | 1,84 | 1,82 | 1,82 | -0,36% | 1,27% | 1.720.397 |
| 27/09/1979 | 1,83 | 1,84 | 1,82 | 1,83 | +0,00% | 1,08% | 1.260.115 |
| 26/09/1979 | 1,81 | 1,85 | 1,81 | 1,83 | +1,47% | 2,20% | 2.769.235 |
| 25/09/1979 | 1,79 | 1,81 | 1,78 | 1,80 | +0,56% | 1,48% | 2.165.587 |
| 24/09/1979 | 1,79 | 1,80 | 1,79 | 1,79 | +0,00% | 0,74% | 1.505.347 |
| 21/09/1979 | 1,78 | 1,80 | 1,78 | 1,79 | +1,31% | 1,12% | 3.301.200 |
| 20/09/1979 | 1,76 | 1,77 | 1,76 | 1,77 | +0,37% | 0,75% | 1.501.574 |
| 19/09/1979 | 1,76 | 1,77 | 1,75 | 1,76 | +0,38% | 1,13% | 1.769.443 |
| 18/09/1979 | 1,77 | 1,77 | 1,74 | 1,76 | -1,12% | 1,50% | 2.127.859 |
| 17/09/1979 | 1,76 | 1,78 | 1,76 | 1,78 | +0,75% | 0,94% | 1.116.749 |
| 14/09/1979 | 1,76 | 1,78 | 1,75 | 1,76 | +0,38% | 1,32% | 1.973.174 |
| 13/09/1979 | 1,75 | 1,77 | 1,75 | 1,76 | +0,19% | 0,94% | 1.471.392 |
| 12/09/1979 | 1,76 | 1,77 | 1,75 | 1,75 | -0,56% | 1,12% | 2.210.861 |
| 11/09/1979 | 1,79 | 1,79 | 1,74 | 1,76 | -1,66% | 2,78% | 3.584.160 |
| 10/09/1979 | 1,79 | 1,80 | 1,78 | 1,79 | +0,18% | 1,11% | 2.018.448 |
| 07/09/1979 | 1,77 | 1,80 | 1,75 | 1,79 | +1,12% | 2,81% | 1.097.885 |
| 06/09/1979 | 1,80 | 1,80 | 1,77 | 1,77 | -1,48% | 1,85% | 4.319.856 |
| 05/09/1979 | 1,81 | 1,81 | 1,79 | 1,80 | -1,46% | 1,10% | 2.142.950 |
| 04/09/1979 | 1,84 | 1,85 | 1,82 | 1,82 | -1,07% | 1,98% | 3.550.205 |
| 31/08/1979 | 1,86 | 1,86 | 1,84 | 1,84 | -1,07% | 1,07% | 980.928 |
| 30/08/1979 | 1,86 | 1,86 | 1,85 | 1,86 | +0,00% | 0,53% | 2.063.722 |